Controlled activation of complement components for use as endogenous adjuvant
- 专利权人:
- 发明人:
- 申请号：
- EP12075058.3
- 公开号：
- EP2674167A1
- 申请日:
- 2012.06.14
- 申请国别(地区):
- EP
- 年份:
- 2013
- 代理人:
- 摘要：
- The invention relates to a pharmaceutical composition made of one or more preparation and comprising a therapeutically effective dose of at least one recombinant human C3-derivative and at least one antigen for vaccination.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Modulation of effector T cell responses by local depletion of complement component C3
- VACCINE ADJUVANT AND MICRONEEDLE PREPARATION
- NUCLEIC ACIDS COMPRISING FORMULA (NUGLXMGNNV)A AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS
- NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS/ADJUVANTS
- BETA-GLYCOLIPIDS FOR USE AS ADJUVANTS
